MNMD — MIND MEDICINE MINDMED INC

Ownership history in CAXTON CORP  ·  10 quarters on record

This page tracks every 13F SEC filing in which CAXTON CORP reported a position in MIND MEDICINE MINDMED INC (MNMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.91% (2012 Q4)
Avg. % of fund
2.72%
First filed
2012 Q4
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 15,688 -11,323 -41.9% 4.91% $210K $13.39
2025 Q3 REDUCED 27,011 -7,062 -20.7% 1.39% $318K $11.79
2025 Q2 UNCHANGED 34,073 — 0% 2.24% $221K $6.49
2025 Q1 UNCHANGED 34,073 — 0% 3.92% $199.3M $5.85
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MNMD price (monthly, adj. close)

Other funds also holding MNMD

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 3.63% Rosalind Advisors, Inc. 3.53% SUPERSTRING CAPITAL MANAGEMENT LP 3.05% Data Collective IV GP, LLC 3Y 2.3% Commodore Capital LP 3Y 1.78% Soviero Asset Management, LP 3Y 0.96% Avoro Capital Advisors LLC 3Y 7Y 0.66% Crawford Fund Management, LLC 0.52% PSP Research LLC 0.41% Deep Track Capital, LP 3Y 0.4%
← Back to CAXTON CORP Holdings